[1]BioorganicandMedicinalChemistryLetters,2012,vol.22,p.7634-7640
[2]BioorganicandMedicinalChemistryLetters,2014,vol.24,p.4630-4637
Title: German, et al. Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases. patent/EP1003721B1